Ottawa, April 20, 2022 – Innovative Medicines Canada (IMC), the association representing Canada’s research-based pharmaceutical sector, issued the following statement in response to the Federal Government’s recent announcement on the […]

IMC is pleased with the ongoing commitments to increased access to innovative medicines and treatments […]

IMC welcomes the federal government’s renewed commitment to enhancing access […]

IMC is saddened and dismayed by Russia’s unprovoked invasion of Ukraine. […]

Our members have never shied away from doing whatever it takes — because it is worth it to provide hope to people when they need it most.